v3.20.2
Identifiable Intangible Assets and Goodwill - Finite-lived and Indefinite-lived Intangible Assets (Detail) - USD ($)
$ in Millions
Sep. 27, 2020
Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross carrying amount $ 93,358 $ 91,425
Finite-lived intangible assets, accumulated amortization [1] (68,216) (65,037)
Finite-lived intangible assets, net 25,142 26,387
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets 5,785 8,983
Intangible assets, gross carrying amount [1] 99,143 100,408
Finite-lived intangible assets, accumulated amortization [1] (68,216) (65,037)
Identifiable Intangible Assets, less Accumulated Amortization [1] 30,927 35,370
Brands [Member]    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets 1,991 1,991
IPR&D [Member]    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets [2] 3,221 5,919
License Agreements and Other [Member]    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets [3] 573 1,073
Developed technology rights [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross carrying amount [4] 90,052 88,730
Finite-lived intangible assets, accumulated amortization [4] (66,212) (63,106)
Finite-lived intangible assets, net [4] 23,840 25,625
Indefinite-lived Intangible Assets [Line Items]    
Finite-lived intangible assets, accumulated amortization [4] (66,212) (63,106)
Brands [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross carrying amount 922 922
Finite-lived intangible assets, accumulated amortization (766) (741)
Finite-lived intangible assets, net 156 181
Indefinite-lived Intangible Assets [Line Items]    
Finite-lived intangible assets, accumulated amortization (766) (741)
License Agreements and Other [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross carrying amount [3] 2,385 1,772
Finite-lived intangible assets, accumulated amortization [3] (1,238) (1,191)
Finite-lived intangible assets, net [3] 1,146 582
Indefinite-lived Intangible Assets [Line Items]    
Finite-lived intangible assets, accumulated amortization [3] $ (1,238) $ (1,191)
[1] The decrease is primarily due to amortization, the $900 million impairment of IPR&D, and measurement period adjustments related to the acquisition of Array.
[2] The changes in the gross carrying amount primarily reflect a $1.2 billion measurement period adjustment related to the acquisition of Array, a $900 million impairment of IPR&D (see Note 4), and the transfer of $600 million from IPR&D to Developed technology rights to reflect the approval of Braftovi in combination with Erbitux® (cetuximab), for the treatment of BRAFV600E-mutant metastatic colorectal cancer after prior therapy.
[3] The changes in the gross carrying amounts primarily reflect the transfer of $600 million from Indefinite-lived Licensing agreements and other to finite-lived Licensing agreements and other to reflect the approval in the U.S. of several products subject to out-licensing arrangements acquired from Array, as well as measurement period adjustments related to the acquisition of Array.
[4] The change in the gross carrying amount primarily reflect the transfer of $600 million from IPR&D to Developed technology rights to reflect the approval of Braftovi in combination with Erbitux® (cetuximab), for the treatment of BRAFV600E-mutant metastatic colorectal cancer after prior therapy and a $200 million measurement period adjustment related to the acquisition of Array (see Note 2A).